Oxford, AstraZeneca to resume Covid-19 vaccine trial after UK patient’s illness

In a statement, the university said in large trials such as this “it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety.”

It said that globally some 18,000 people have received the vaccine as part of the trial. 

It would not disclose information about the patient’s illness for reasons of participant confidentiality but insisted that it is “committed to the safety of our participants and the highest…

Read Full Article

LEAVE A REPLY

Please enter your comment!
Please enter your name here